| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1541-7786.MCR-08-0035 |
| P698 | PubMed publication ID | 18644979 |
| P50 | author | Xin-Yuan Guan | Q39845550 |
| Stephanie Ma | Q55948463 | ||
| Terence Kin-Wah Lee | Q73885432 | ||
| P2093 | author name string | Bo-Jian Zheng | |
| Kwan Ho Tang | |||
| Kwok Wah Chan | |||
| Jana Yim-Hung Wo | |||
| P433 | issue | 7 | |
| P921 | main subject | liver cancer | Q623031 |
| neoplastic stem cells | Q1638475 | ||
| P304 | page(s) | 1146-1153 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Molecular Cancer Research | Q2751014 |
| P1476 | title | Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations | |
| P478 | volume | 6 |
| Q35768905 | A Novel Microtubule-Disrupting Agent Induces Endoplasmic Reticular Stress-Mediated Cell Death in Human Hepatocellular Carcinoma Cells. |
| Q37334258 | A quest for initiating cells of head and neck cancer and their treatment |
| Q41623505 | A reliable method for the sorting and identification of ALDHhigh cancer stem cells by flow cytometry |
| Q64101498 | A robust culture method for maintaining tumorigenic cancer stem cells in the hepatocellular carcinoma cell line Li-7 |
| Q24649718 | ALDH1 expression correlates with favorable prognosis in ovarian cancers |
| Q36278116 | ALDH1 might influence the metastatic capability of HeLa cells |
| Q36413028 | ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma |
| Q38743865 | ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment |
| Q34838175 | Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas |
| Q35140669 | Acetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancers |
| Q41819679 | Activation of the sonic hedgehog signaling pathway occurs in the CD133 positive cells of mouse liver cancer Hepa 1-6 cells |
| Q37522515 | Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma. |
| Q61818599 | Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells |
| Q38430100 | Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma |
| Q35168501 | Aldehyde dehydrogenase 1 (ALDH1) positivity correlates with poor prognosis in cervical cancer |
| Q28534236 | Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell line |
| Q26771185 | Aldehyde dehydrogenase 1A1 in stem cells and cancer |
| Q39925109 | Aldehyde dehydrogenase activity as a functional marker for lung cancer |
| Q35022205 | Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival |
| Q37610799 | Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies |
| Q33275167 | An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma |
| Q34900602 | Analysis of volatile organic compounds liberated and metabolised by human umbilical vein endothelial cells (HUVEC) in vitro |
| Q39744887 | Androgen deprivation and stem cell markers in prostate cancers. |
| Q38713045 | Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency. |
| Q51701639 | Assessment of ovarian cancer conditions from exhaled breath. |
| Q38937195 | BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation |
| Q38045627 | Biology and clinical implications of CD133(+) liver cancer stem cells. |
| Q37873961 | Biology of hepatic cancer stem cells. |
| Q27004622 | Biology of renal tumour cancer stem cells applied in medicine |
| Q64236045 | Biophysical Phenotyping and Modulation of ALDH+ Inflammatory Breast Cancer Stem-Like Cells |
| Q42056048 | Butein inhibits ethanol-induced activation of liver stellate cells through TGF-β, NFκB, p38, and JNK signaling pathways and inhibition of oxidative stress |
| Q40744258 | C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties. |
| Q38035206 | CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges |
| Q36170883 | CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells |
| Q38922806 | CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality? |
| Q37190326 | CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment |
| Q55254109 | Cancer Stem Cells are Regulated by STAT3 Signalling in Wilms Tumour. |
| Q39817310 | Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma |
| Q92358663 | Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45+CD19- cells but in the ALDHhigh Cells |
| Q50027179 | Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases |
| Q38808963 | Cancer Stem Cells: Formidable Allies of Cancer |
| Q47133533 | Cancer cell reprogramming to identify the genes competent for generating liver cancer stem cells |
| Q26740619 | Cancer of the Pancreas: Molecular Pathways and Current Advancement in Treatment |
| Q38234251 | Cancer stem cell detection and isolation |
| Q42006656 | Cancer stem cell markers in head and neck squamous cell carcinoma. |
| Q38089898 | Cancer stem cell markers: what is their diagnostic value? |
| Q37920789 | Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges |
| Q37919424 | Cancer stem cells in head and neck squamous cell carcinoma: a review of current knowledge and future applications |
| Q38540375 | Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology |
| Q36793453 | Cancer stem cells in the development of liver cancer |
| Q27025165 | Cancer stem cells--the current status of an old concept: literature review and clinical approaches |
| Q37621777 | Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis |
| Q37815127 | Cancer stem cells: problems for therapy? |
| Q35280672 | Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs |
| Q37323724 | Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling |
| Q24707869 | Carcinogenic Effects of “Whole-Life” Exposure to Inorganic Arsenic in CD1 Mice |
| Q33688897 | Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN. |
| Q38046107 | Cellular and molecular mechanisms of hepatocellular carcinoma: an update |
| Q36111589 | Characterization of liposarcoma cell lines for preclinical and biological studies |
| Q34043793 | Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells |
| Q30843748 | Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells |
| Q34357073 | Clinical implications of cancer stem cell biology in hepatocellular carcinoma |
| Q53526112 | Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis. |
| Q37697137 | Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer |
| Q55303619 | Comparative proteomics of side population cells derived from human hepatocellular carcinoma cell lines with varying metastatic potentials. |
| Q52612153 | Comparison of protein expression between human livers and the hepatic cell lines HepG2, Hep3B, and Huh7 using SWATH and MRM-HR proteomics: Focusing on drug-metabolizing enzymes. |
| Q36052189 | Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer |
| Q26786047 | Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells |
| Q37687361 | Cyr61-positive cancer stem-like cells enhances distal metastases of pancreatic cancer |
| Q92840638 | DKK1 maintained cancer stem-like properties of esophageal carcinoma cells via ALDH1A1/SOX2 axis |
| Q64076943 | Definition of a multiple myeloma progenitor population in mice driven by enforced expression of XBP1s |
| Q35529398 | Dendritic cells loaded with pancreatic Cancer Stem Cells (CSCs) lysates induce antitumor immune killing effect in vitro |
| Q35815783 | Design and Characterization of Bioengineered Cancer-Like Stem Cells |
| Q36577658 | Detection of ALDH1 activity in rabbit hepatic VX2 tumors and isolation of ALDH1 positive cancer stem cells |
| Q34968735 | Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention. |
| Q37339931 | Die hard: are cancer stem cells the Bruce Willises of tumor biology? |
| Q37534779 | Differential Cytotoxic Potential of Silver Nanoparticles in Human Ovarian Cancer Cells and Ovarian Cancer Stem Cells |
| Q34500251 | Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors. |
| Q90250266 | Digging deeper into volatile organic compounds associated with cancer |
| Q90239259 | Dishevelled 1-Regulated Superpotent Cancer Stem Cells Mediate Wnt Heterogeneity and Tumor Progression in Hepatocellular Carcinoma |
| Q37687392 | Do stem-like cells play a role in drug resistance of sarcomas? |
| Q37039311 | Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties |
| Q28477091 | Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms |
| Q27309004 | Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia |
| Q34256683 | Efficient enrichment of hepatic cancer stem-like cells from a primary rat HCC model via a density gradient centrifugation-centered method |
| Q38725554 | Emerging importance of dietary phytochemicals in fight against cancer: Role in targeting cancer stem cells |
| Q35832198 | Enhancement of tumor initiation and expression of KCNMA1, MORF4L2 and ASPM genes in the adenocarcinoma of lung xenograft after vorinostat treatment |
| Q36382605 | Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications |
| Q38969232 | Epithelial cell adhesion molecule-positive human hepatic neoplastic cells: development of combined hepatocellular-cholangiocarcinoma in mice |
| Q38533025 | Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations |
| Q88105265 | Eradicating Cancer Stem Cells: Concepts, Issues, and Challenges |
| Q45069471 | Evaluation and Isolation of Cancer Stem Cells Using ALDH Activity Assay |
| Q54178248 | Evaluation of the selective toxic effect of the charge switchable diethyldithiocarbamate-loaded nanoparticles between hepatic normal and cancerous cells. |
| Q33815175 | Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma |
| Q41449151 | Evidence of CD90+CXCR4+ cells as circulating tumor stem cells in hepatocellular carcinoma |
| Q35190005 | Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells |
| Q38436492 | Expression of cancer stem cell marker during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. |
| Q45396030 | Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia |
| Q37789712 | Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose? |
| Q41468587 | Flow cytometric detection of the classical hodgkin lymphoma: clinical and research applications |
| Q35726927 | FoxO1-negative cells are cancer stem-like cells in pancreatic ductal adenocarcinoma |
| Q38966867 | GFP stable transfection facilitated the characterization of lung cancer stem cells |
| Q47138375 | Gemcitabine treatment causes resistance and malignancy of pancreatic cancer stem-like cells via induction of lncRNA HOTAIR. |
| Q57046983 | Generation and characterization of hepatocellular carcinoma cell lines with enhanced cancer stem cell potential |
| Q36499805 | Ginsenoside Rh2 inhibits hepatocellular carcinoma through β-catenin and autophagy |
| Q52679547 | Graphene Oxide-Silver Nanocomposite Enhances Cytotoxic and Apoptotic Potential of Salinomycin in Human Ovarian Cancer Stem Cells (OvCSCs): A Novel Approach for Cancer Therapy. |
| Q99725823 | HDAC9 Is Preferentially Expressed in Dedifferentiated Hepatocellular Carcinoma Cells and Is Involved in an Anchorage-Independent Growth |
| Q53250113 | HepG2 cells acquire stem cell-like characteristics after immune cell stimulation. |
| Q37821305 | Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma. |
| Q37099380 | Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma |
| Q37288364 | Hepatocellular carcinoma stem cell-like cells are enriched following low-dose 5-fluorouracil chemotherapy |
| Q39010583 | High ALDH1 expression correlates with better prognosis in tumorigenic malignant melanoma |
| Q55471366 | HuH-7 reference genome profile: complex karyotype composed of massive loss of heterozygosity. |
| Q90411196 | Human Hepatic Cancer Stem Cells (HCSCs) Markers Correlated With Immune Infiltrates Reveal Prognostic Significance of Hepatocellular Carcinoma |
| Q90330716 | Hypoxic niches are endowed with a protumorigenic mechanism that supersedes the protective function of PTEN |
| Q39194449 | Identification and evaluation of putative tumour-initiating cells in canine malignant melanoma cell lines |
| Q36642849 | Identification of ABCG2⁺ cells in nasopharyngeal carcinoma cells |
| Q21560783 | Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma |
| Q35078367 | Identification of a population of epidermal squamous cell carcinoma cells with enhanced potential for tumor formation |
| Q35410105 | Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib |
| Q64911634 | Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay. |
| Q33976481 | Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma |
| Q27014031 | Immunotargeting of cancer stem cells |
| Q42717496 | Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment |
| Q37229285 | In search of liver cancer stem cells. |
| Q34761998 | Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression |
| Q33961542 | Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. |
| Q38782085 | Isolation and Characterization of Cancer Stem Cells of the Non-Small-Cell Lung Cancer (A549) Cell Line. |
| Q36689002 | Knock out CD44 in reprogrammed liver cancer cell C3A increases CSCs stemness and promotes differentiation |
| Q36621286 | Label-free quantitative proteomics of CD133-positive liver cancer stem cells |
| Q38964793 | Lgr5-positive cells are cancer stem cells in skin squamous cell carcinoma |
| Q49175481 | Lidamycin decreases CD133 expression in hepatocellular carcinoma via the Notch signaling pathway |
| Q35958012 | Liposarcoma Cells with Aldefluor and CD133 Activity have a Cancer Stem Cell Potential |
| Q41670848 | Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells |
| Q26751026 | Liver cancer stem cell markers: Progression and therapeutic implications |
| Q39000927 | Liver cancer stem cells are selectively enriched by low-dose cisplatin |
| Q45073105 | LncAPC drives Wnt/β-catenin activation and liver TIC self-renewal through EZH2 mediated APC transcriptional inhibition |
| Q52356912 | LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation. |
| Q55428978 | LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner. |
| Q60045078 | LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation |
| Q54419963 | LncMAPK6 drives MAPK6 expression and liver TIC self-renewal. |
| Q35132433 | Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma |
| Q36591484 | Mechanisms of chemoresistance in cancer stem cells |
| Q64226720 | Meeting the Challenge of Targeting Cancer Stem Cells |
| Q36026661 | Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis |
| Q53290459 | MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. |
| Q38086010 | MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells |
| Q35670582 | Modified Leukocyte Filter Removes Tumor Cells from the Salvaged Blood |
| Q38796320 | Modifying the tumor microenvironment using nanoparticle therapeutics |
| Q26822406 | Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers |
| Q33661278 | More than markers: biological significance of cancer stem cell-defining molecules |
| Q42366726 | Murine hepatocellular carcinoma derived stem cells reveal epithelial-to-mesenchymal plasticity. |
| Q34128316 | Musashi1 regulates breast tumor cell proliferation and is a prognostic indicator of poor survival |
| Q39200398 | Novel markers for circulating tumor stem cells in colorectal carcinoma |
| Q64964513 | Nuclear CD44 Mediated by Importin β Participated in Naïve Genes Transcriptional Regulation in C3A-iCSCs. |
| Q34233172 | Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells |
| Q33713657 | Oncolytic reovirus effectively targets breast cancer stem cells |
| Q34147649 | Oral epithelial stem cells - implications in normal development and cancer metastasis |
| Q38197503 | Orchestration of hepatocellular carcinoma development by diverse liver cancer stem cells |
| Q37238378 | Osteosarcoma: mouse models, cell of origin and cancer stem cell |
| Q21245704 | PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis |
| Q91560799 | Pan-cancer genomic amplifications underlie a WNT hyperactivation phenotype associated with stem cell-like features leading to poor prognosis |
| Q64095526 | Phenethyl Isothiocyanate Exposure Promotes Oxidative Stress and Suppresses Sp1 Transcription Factor in Cancer Stem Cells |
| Q52641596 | Phthalate exposure promotes chemotherapeutic drug resistance in colon cancer cells. |
| Q64122994 | Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells |
| Q38089206 | Preclinical development of cancer stem cell drugs |
| Q92462428 | Preclinical verification of the efficacy by targeting peptide-linked liposomal nanoparticles for hepatocellular carcinoma therapy |
| Q33698761 | Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma |
| Q38027219 | Proteomics in studying cancer stem cell biology |
| Q37406832 | Radiation induces the generation of cancer stem cells: A novel mechanism for cancer radioresistance |
| Q28475645 | Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migration |
| Q38552115 | Recent insights into hepatic cancer stem cells |
| Q38978893 | Regulation of tumor progression via the Snail-RKIP signaling pathway by nicotine exposure in head and neck squamous cell carcinoma |
| Q36583430 | Regulatory role of hexosamine biosynthetic pathway on hepatic cancer stem cell marker CD133 under low glucose conditions |
| Q34840709 | Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro |
| Q27022262 | Research progress and prospects of markers for liver cancer stem cells |
| Q33869770 | Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness. |
| Q41613353 | Ribonucleic acid interference knockdown of IL-6 enhances the efficacy of cisplatin in laryngeal cancer stem cells by down-regulating the IL-6/STAT3/HIF1 pathway. |
| Q47137381 | Road to stemness in hepatocellular carcinoma |
| Q33940830 | Role for putative hepatocellular carcinoma stem cell subpopulations in biological response to incomplete thermal ablation: in vitro and in vivo pilot study. |
| Q37153640 | Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal |
| Q47141366 | SAMMSON drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/β-catenin activation |
| Q38117949 | Salivary gland cancer stem cells |
| Q34978487 | Seeing is Believing: Are Cancer Stem Cells the Loch Ness Monster of Tumor Biology? |
| Q47111973 | Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma |
| Q37809348 | Stem Cells in Normal Development and Cancer |
| Q37508765 | Stem cells and solid cancers |
| Q37985376 | Stem cells in brain tumour development and therapy- two-sides of the same coin. |
| Q33533408 | Stem cells in hepatocarcinogenesis: evidence from genomic data |
| Q35631841 | Stem cells in liver diseases and cancer: recent advances on the path to new therapies |
| Q28079205 | Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer |
| Q37688113 | Study on the Biological Characteristics of CD133 (+) Cells Interfered by RNA Interference in Gastric Cancer |
| Q50053655 | Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC. |
| Q36087138 | Survival of skin cancer stem cells requires the Ezh2 polycomb group protein. |
| Q39273399 | Susceptibility to cytotoxic T cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines |
| Q64113617 | TARBP2-mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma |
| Q34523263 | Tackling the cancer stem cells - what challenges do they pose? |
| Q38114000 | Targeted therapy aimed at cancer stem cells: Wilms' tumor as an example |
| Q64114256 | Targeting AMP-activated kinase impacts hepatocellular cancer stem cells induced by long-term treatment with sorafenib |
| Q39321673 | Targeting Lung Cancer Stem Cells: Research and Clinical Impacts |
| Q26783590 | Targeting cancer stem cells by using the nanoparticles |
| Q42182917 | Targeting cancer stem cells: a new therapy to cure cancer patients. |
| Q34335524 | Targeting the osteosarcoma cancer stem cell |
| Q48159512 | The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer. |
| Q28071619 | The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma |
| Q53106095 | The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy. |
| Q38155666 | The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy |
| Q35958822 | The critical role of CD133(+)CD44(+/high) tumor cells in hematogenous metastasis of liver cancers |
| Q41845773 | The dental pulp stem cell niche based on aldehyde dehydrogenase 1 expression |
| Q33885293 | The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients |
| Q55617784 | The evolving concepts of cancer stem cells in head and neck squamous cell carcinoma. |
| Q36516688 | The expression of ALDH1 in cervical carcinoma |
| Q37705401 | The expression of aldehyde dehydrogenase family in breast cancer |
| Q38045265 | The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy. |
| Q33724839 | The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells |
| Q36538487 | The implications of cancer stem cells for cancer therapy |
| Q36602158 | The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets |
| Q52431077 | The long noncoding RNA lncZic2 drives the self-renewal of liver tumor-initiating cells via the protein kinase C substrates MARCKS and MARCKSL1. |
| Q38258638 | The miRNA23b-regulated signaling network as a key to cancer development--implications for translational research and therapeutics |
| Q43246238 | The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor. |
| Q37940376 | The proteomics of cancer stem cells: potential clinical applications for innovative research in oncology |
| Q37863625 | The role of stem and circulating cells in cancer metastasis |
| Q36152438 | The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs) |
| Q35404189 | Therapeutic application of stem cells in gastroenterology: an up-date |
| Q38476083 | Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment |
| Q33889185 | Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent |
| Q27692697 | Turning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives. |
| Q64103221 | Unique Gene Expression Signatures in the Intestinal Mucosa and Organoids Derived from Germ-Free and Monoassociated Mice |
| Q93007759 | Unraveling the journey of cancer stem cells from origin to metastasis |
| Q49425617 | Upregulation of ALDH1B1 promotes tumor progression in osteosarcoma |
| Q55023339 | Volatile metabonomic profiling in urine to detect novel biomarkers for B-cell non-Hodgkin's lymphoma. |
| Q38957666 | Zebrafish xenotransplantation model for cancer stem-like cell study and high-throughput screening of inhibitors |
| Q90365948 | miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features |
| Q36322395 | miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90(+) HepG2 cells |
Search more.